High-dose Sulbactam Treatment for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant

High-dose Sulbactam Treatment for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant

Background Several antibiotics can be used to treat ventilator-associated pneumonia caused by carbapenem-resistant A. baumannii (CRAB-VAP) including high-dose sulbactam. However, the effectiveness of high-dose sulbactam therapy is not well known. We report our experience with high-dose sulbactam for...

Full description

Bibliographic Details
Main Authors:	In Beom Jeong, Moon Jun Na, Ji Woong Son, Do Yeon Jo, Sun Jung Kwon
Format:	Article
Language:	English
Published:	Korean Society of Critical Care Medicine 2016-11-01
Series:	Korean Journal of Critical Care Medicine
Subjects:	acinetobacter pneumonia, ventilator-associated sulbactam
Online Access:	http://kjccm.org/upload/pdf/kjccm-2015-00703.pdf

Similar Items

Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii
by: Kanchanasuwan S, et al.
Published: (2021-03-01)

Pharmacodynamic assessment of Amoxicillin-Sulbactam against Acinetobacter baumannii: searching the optimal dose and infusion time through a human ex-vivo model
by: Carlos Bantar, et al.

Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates
by: Jose Cedano, et al.
Published: (2022-07-01)

A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) Isolates
by: Fernando Pasteran, et al.
Published: (2021-05-01)

Determination of Susceptibility Rates of Nosocomial Acinetobacter baumannii Isolates to Sulbactam by E-test Method
by: Fatih Temoçin, et al.
Published: (2017-03-01)

In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance
by: Jacqueline Findlay, et al.
Published: (2022-09-01)

<i>Acinetobacter baumannii</i> Resistance to Sulbactam/Durlobactam: A Systematic Review
by: Luigi Principe, et al.
Published: (2022-12-01)

Investigation of the Synergic Effect of the Colistin/ Sulbactam Combination in Carbapenem-Resistant Acinetobacter baumannii complex Strains with Time-Kill and Checkerboard Methods
by: İmdat KILBAŞ, et al.
Published: (2021-03-01)

Hypothermia from a two‐component mixture comprising Amoxicillin and Sulbactam
by: Tung Anh Dinh Duong, et al.
Published: (2020-06-01)

The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant Acinetobacter baumannii
by: Jiayuan Zhang, et al.
Published: (2022-11-01)

Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
by: Shu-Chen eKuo, et al.
Published: (2015-03-01)

Clinical Outcomes Of Colistin In Combination With Either 6-G Sulbactam Or Carbapenems For The Treatment Of Extensively Drug-Resistant Acinetobacter Baumannii Pneumonia With High MIC To Sulbactam, A Prospective Cohort Study
by: Ungthammakhun C, et al.
Published: (2019-09-01)

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis
by: Haiqing Chu, et al.

Perfil de Sulbactam/ Ampicilina y Sulbactam/Cefoperazona en la Práctica Clínica
by: Guillermo Prada
Published: (2021-10-01)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023-12-01)

Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against Acinetobacter baumannii
by: Shixing Zhu, et al.
Published: (2023-06-01)

Alteration of adeS Contributes to Tigecycline Resistance and Collateral Sensitivity to Sulbactam in Acinetobacter baumannii
by: Yunxing Yang, et al.
Published: (2023-06-01)

Ampicillin-Sulbactam for the Treatment of Aspiration Pneumonia in Patients with Opioid Overdose: A Randomized Controlled Clinical Trial
by: Mohammadreza Tabatabaei, et al.
Published: (2021-11-01)

Targeting Multidrug-Resistant <italic toggle="yes">Acinetobacter</italic> spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
by: Melissa D. Barnes, et al.
Published: (2019-04-01)

Expression analysis of drug-resistant gene (blaOXA-51) in carbapenemases producing Acinetobacter baumannii treated with imipenem/sulbactam combination
by: Saber Noshadi, et al.
Published: (2021-10-01)

Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
by: Hideo Kato, et al.
Published: (2022-09-01)

Coagulopathy Induced by Cefoperazone/Sulbactam in a Geriatric Patient
by: Ergenekon Karagoz, et al.
Published: (2015-12-01)

Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates in a Hollow-Fibre Infection Model
by: Sazlyna Mohd Sazlly Lim, et al.
Published: (2022-11-01)

Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against <i>Acinetobacter baumannii</i> in Patients with Hospital-Acquired Pneumonia
by: Yingjie Zhou, et al.
Published: (2022-05-01)

Effects of amikacin, polymyxin-B, and sulbactam combination on the pharmacodynamic indices of mutant selection against multi-drug resistant Acinetobacter baumannii
by: Shixing Zhu, et al.
Published: (2022-10-01)

The known-unknown: third- and fourth-generation cephalosporins combined with sulbactam
by: Stetsiouk O.U., et al.
Published: (2023-03-01)

Mortality and ventilator dependence in critically ill patients with ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii
by: Hsiao-Hui Kao, et al.
Published: (2023-08-01)

Tracking cefoperazone/sulbactam resistance development in vivo in A. baumannii isolated from a patient with hospital-acquired pneumonia by whole-genome sequencing
by: Xiaofen Liu, et al.
Published: (2016-08-01)

Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation
by: Xueting Wang, et al.
Published: (2023-02-01)

Optimal Dose of Cefoperazone-Sulbactam for Acute Bacterial Infection in Patients with Chronic Kidney Disease
by: Chien-Ming Chao, et al.
Published: (2022-04-01)

Cefotaxime/sulbactam: clinical and pharmacological characteristics
by: Ortenberg E.A., et al.
Published: (2019-12-01)

Assessment of Effective Antimicrobial Regimens and Mortality-Related Risk Factors for Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
by: Gu S, et al.
Published: (2023-05-01)

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including <i>Acinetobacter baumannii</i>
by: Tetsushu Onita, et al.
Published: (2023-02-01)

The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial
by: Mahnaz Momenzadeh, et al.
Published: (2023-01-01)

Molecular Identification of Carbapenem Resistance Acinetobacter baumannii causing Ventilator-Associated Pneumonia Isolated from Intensive Care Unit of Tertiary Care Hospital
by: Vijeta Sharma, et al.
Published: (2024-03-01)

Prevalence of ventilator-associated events and antibiogram of bacterial isolates of ventilator-associated pneumonia in a tertiary care hospital of Uttarakhand
by: Abhishek Kori, et al.
Published: (2023-11-01)

Risk Factors for Cefoperazone/Sulbactam-Induced Coagulation Disorder
by: Miao W, et al.
Published: (2023-09-01)

A Comparative Study of the Prevalence of Bacterial Strains in Early and Late-Onset Ventilator-Associated Pneumonia in Critically Ill Patients
by: Babak Alikiaii, et al.
Published: (2018-02-01)

Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysis
by: Jiating Liu, et al.
Published: (2021-03-01)

Antibiotic Resistance Patterns and Detection of OXA-23 and OXA-48 Genes in Acinetobacter baumannii Isolated from Ventilator Associated Pneumonia
by: Ahmad Rastegar Lari, et al.
Published: (2019-06-01)